Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842868 · ClinicalTrials.gov registry record
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 1,298
- Enrollment target
NCT00842868: Completed study, sponsored by Massachusetts General Hospital.
NCT00842868 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,298 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00842868 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 1,298 participants
- Enrollment target
Study Summary
The purpose of this research is to determine the relationship between novel blood tests for heart function (including hormones and heart enzymes measured in the blood), and assess for kidney damage before and after angiography (cardiac catheterization). We hypothesize that these novel tests will enable us to predict possible complications of catheterization immediately after the procedure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,298 participants |
| Start Date | 2008-09 |
| Est. Completion | 2015-03 |
What the finished NCT00842868 record still lists
NCT00842868 is an observational study that tracks outcomes without assigning an intervention. Its 1,298 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00842868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00842868 about?
NCT00842868 is a clinical study titled "The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases". The purpose of this research is to determine the relationship between novel blood tests for heart function (including hormones and heart enzymes measured in the blood), and assess for kidney damage before and after angiography (cardiac catheterization). We hypothesize that these novel tests will ena...
What is the current status of trial NCT00842868?
This trial is currently completed. The enrollment target is 1,298 participants. The study started on 2008-09. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT00842868?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia